Reaction Details Report a problem with these data
Target
Proteasome subunit beta type-2
Ligand
BDBM50398609
Substrate
n/a
Meas. Tech.
ChEMBL_1901151 (CHEMBL4403373)
IC50
30±n/a nM
Citation
 Xi, J; Zhuang, R; Kong, L; He, R; Zhu, H; Zhang, J Immunoproteasome-selective inhibitors: An overview of recent developments as potential drugs for hematologic malignancies and autoimmune diseases. Eur J Med Chem 182:0 (2019) [PubMed]  Article 
Target
Name:
Proteasome subunit beta type-2
Synonyms:
20S proteasome | PSB2_HUMAN | PSMB2 | Proteasome Macropain subunit
Type:
PROTEIN
Mol. Mass.:
22837.53
Organism:
Homo sapiens (Human)
Description:
ChEMBL_1294233
Residue:
201
Sequence:
MEYLIGIQGPDYVLVASDRVAASNIVQMKDDHDKMFKMSEKILLLCVGEAGDTVQFAEYIQKNVQLYKMRNGYELSPTAAANFTRRNLADCLRSRTPYHVNLLLAGYDEHEGPALYYMDYLAALAKAPFAAHGYGAFLTLSILDRYYTPTISRERAVELLRKCLEELQKRFILNLPTFSVRIIDKNGIHDLDNISFPKQGS
  
Inhibitor
Name:
BDBM50398609
Synonyms:
CHEMBL2141296 | IXAZOMIB CITRATE | Ixazomib | MLN2238 | NINLARO
Type:
Small organic molecule
Emp. Form.:
C14H19BCl2N2O4
Mol. Mass.:
361.029
SMILES:
CC(C)C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B(O)O
Structure:
Search PDB for entries with ligand similarity: